Home > Financial Ratios > KOPRAN

KOPRAN
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for KOPRAN
Please provide your vote to see the results

KOPRAN Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 62.27-44.02-1.77110.80-4.18

What is the latest Core EBITDA Growth ratio of KOPRAN ?

The latest Core EBITDA Growth ratio of KOPRAN is 62.27 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202462.27
Mar2023-44.02
Mar2022-1.77
Mar2021110.80
Mar2020-4.18

How is Core EBITDA Growth of KOPRAN Trending?

Years Core EBITDA Growth % Change
Mar2024 62.27
Positive
Mar2023 -44.02
Negative
Mar2022 -1.77
Negative
Mar2021 110.8
Positive
Mar2020 -4.18 -

Other Financial Ratios of KOPRAN


Compare Core EBITDA Growth ratio of peers of KOPRAN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KOPRAN ₹861.4 Cr -6.1% -3.3% -26.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,648.0 Cr -4.9% 2.1% 15.5% Stock Analytics
DIVIS LABORATORIES ₹159,310.0 Cr -2.2% 9.3% 50.5% Stock Analytics
CIPLA ₹119,410.0 Cr -4.2% 4.5% 4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹106,189.0 Cr -4.4% -4.5% 17.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,496.4 Cr -1.4% 4.2% -8.8% Stock Analytics


KOPRAN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KOPRAN

-6.1%

-3.3%

-26.8%

SENSEX

-1.3%

4.1%

7.6%


You may also like the below Video Courses